Status:
UNKNOWN
Omics-based Precision Medicine of Epilepsy
Lead Sponsor:
Fudan University
Collaborating Sponsors:
Huashan Hospital
Peking University First Hospital
Conditions:
Epilepsy Idiopathic
Clinical Disease and/or Syndrome
Eligibility:
All Genders
Up to 65 years
Brief Summary
Epilepsy is a major disease of the nervous system (WHO, 2015), as well as the second most common neural disease. It has been recorded that there have been 65 million epilepsy patients all over the wor...
Detailed Description
Research projects: Part 1: Based on already existed large samples of epilepsy clinical cases, choose 2,0000 non-acquired epilepsy patients for clinical general phenotype and middle phenotype(EEG and ...
Eligibility Criteria
Inclusion
- non-acquired epilepsy; family involved(children, father and mother); Han nationality; Consent and will to follow up
Exclusion
- Acquired epilepsy; Very low birth weight infant
Key Trial Info
Start Date :
November 25 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03358459
Start Date
November 25 2017
End Date
July 1 2018
Last Update
November 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 201102